Amino Acid Analysis — The Third Identity Test Most Lot Reports Skip
RP-HPLC tells you purity. ESI-MS tells you molecular mass. Amino acid analysis (AAA) tells you composition — which residues, in what stoichiometry — by a method orthogonal to both. What AAA actually measures, where it catches errors the other two methods can't, and the residue-class limitations every interpretation needs to account for.
Published May 25, 2026 · 7 min read · By Lyochem Regulatory Team
A peptide release packet usually leans on two analytics: reversed-phase HPLC (purity) and electrospray mass spectrometry (mass identity). For most research workflows that pairing is sufficient. The third leg — amino acid analysis (AAA) — gets routinely added on biologics-grade material and routinely skipped on research-grade. The skip is sometimes appropriate and sometimes a real gap. This Note explains what AAA actually measures, where it catches errors the other two methods can't see, and how to read an AAA report alongside the HPLC and MS data.
What AAA actually does
The method has three stages:
- **Acid hydrolysis**: the peptide is hydrolyzed in 6 M HCl at 110 °C for 20-24 hours, typically in the vapour phase. The hydrolysis breaks every peptide bond, releasing free amino acids into solution.
- **Separation**: the released amino acids are separated by ion-exchange chromatography (the classical Stein-Moore approach) or by RP-HPLC after pre-column derivatization (more common in modern instruments).
- **Detection and quantification**: post-column ninhydrin reaction generates absorbance at 570 nm for primary amines and 440 nm for the secondary amine of proline. Each amino acid produces a peak at its characteristic retention time; peak area calibrated against a reference standard mixture gives moles per amino acid.
Total moles divided by the labelled molecular formula gives the moles of peptide. Comparing observed moles per residue to theoretical gives the composition match. The full USP framework is in [General Chapter ⟨1052⟩ Biotechnology-Derived Articles — Amino Acid Analysis](https://www.usp.org/sites/default/files/usp/document/harmonization/biotechnology/harmonization_april_2017_m858.pdf).
The output is a per-residue table comparing measured vs theoretical molar ratios — for a 25-mer with three Lys, theoretical Lys ratio is 3.0; an observed Lys ratio of 2.8 ± 0.1 is consistent; an observed Lys ratio of 1.9 ± 0.1 indicates a real composition discrepancy.
What AAA catches that HPLC + MS miss
The standard release pair (HPLC purity + MS mass) leaves two specific gaps:
Gap 1 — gross composition errors that happen to share total mass. A 25-mer where the synthesis substituted one Leu for one Ile shares the exact same molecular formula and mass (Leu and Ile are isomers, both C₆H₁₁NO). ESI-MS shows perfect mass agreement; HPLC retention time may be slightly different but within the same general region. AAA cannot distinguish Leu from Ile either (they elute as a combined peak on the standard ion-exchange column), but it catches the broader class of composition swaps where the substituting amino acid is from a different class — e.g. a Lys-for-Gln substitution (mass diff ~0.04 Da, easily missed on standard-resolution MS) is unambiguous on AAA (Lys at 128.18 Da, Gln at 128.13 Da, but composition-wise they go to different peaks: Lys vs Gln on the AAA trace).
Gap 2 — quantification independent of molar absorptivity. Most research peptides are quantified by absorbance at 214 nm or 280 nm, with the molar extinction coefficient estimated from the sequence (sum of Trp, Tyr, Phe contributions for 280 nm). If the sequence lacks Trp/Tyr (common for many small bioactive peptides), 280 nm quantification fails entirely; 214 nm quantification is sensitive to small impurities. AAA quantifies the peptide directly by amino-acid content, independent of any extinction coefficient assumption. For accurate per-mole dose calculations in dose-response work, AAA is the reference method.
What AAA cannot tell you
The classical hydrolysis conditions destroy or modify specific residues:
| Residue | Fate during acid hydrolysis | What this means for AAA |
|---|---|---|
| **Trp** | Completely destroyed | Cannot quantify; sequence must be otherwise verified for Trp |
| **Cys** | Partially destroyed unless pre-derivatized | Underreports; pre-oxidation to cysteic acid gives a quantifiable derivative |
| **Met** | Partially oxidized to Met-sulfoxide | Slight underreport; sulfoxide can be back-quantified |
| **Asn / Gln** | Both deamidated to Asp / Glu during hydrolysis | The AAA Asx peak combines Asn + Asp; Glx combines Gln + Glu. Cannot distinguish |
| **Ser / Thr** | Slow destruction during 24h hydrolysis | Typical 5-10% loss; correction factors applied |
| **Leu / Ile** | Co-elute on standard ion-exchange separation | Reported as combined |
These limitations are why AAA is the third leg, not the only test. It catches composition errors but it does not catch sequence-order errors and it cannot quantify Trp at all.
When AAA matters most
AAA is most useful at three points in a project:
- **First lot of a new peptide source.** Cross-checking the composition against the labelled sequence catches gross errors at the supplier level. After the first qualified lot, mass + HPLC are usually sufficient for follow-up lots from the same supplier.
- **Accurate per-mole dosing.** For dose-response work where the question is "what concentration produces the half-maximal effect," peptide quantification by AAA gives a more accurate per-mole value than UV absorbance-based methods.
- **When the peptide has no Trp / Tyr / Phe.** UV at 280 nm doesn't work; 214 nm is impurity-sensitive; AAA becomes the primary quantification.
For routine in-vitro work using a well-qualified peptide source, AAA is often appropriate to ask for once (on the qualifying first lot) and not for every subsequent lot. For dose-response work and for any per-mole quantitative claim, ask for it.
What Lyochem ships and what's on request
Every Lyochem reference-grade lot ships with AAA on the release packet — composition table with measured vs theoretical molar ratios for each amino acid present in the sequence. The Asx/Glx combination and Trp/Cys limitations are noted explicitly on the report.
Available on request for sequences with specific quantitation requirements: - Pre-column derivatization (PITC, AQC, or OPA) for higher sensitivity and better separation of close-eluting residues - Cysteic-acid oxidation pre-treatment for accurate Cys quantitation - Tryptophan-specific quantitation by alternative methods (alkaline hydrolysis or HCl + thioglycolic acid) - Reference-standard validation matching the buyer's specific reference
Reading the AAA report
A clean AAA report shows measured/theoretical ratios within ±10% of 1.0 for each non-destroyed residue. Ratios outside ±15% indicate a real composition discrepancy that should be discussed with the supplier — either an analytical artifact (correctable) or a real composition issue (different lot needed).
If the report shows Asx ratio of 2.0 ± 0.1 for a sequence with one Asn + one Asp (theoretical Asx = 2): consistent. If the Asx ratio is 1.6, either deamidation extent was atypical or the sequence is genuinely off. The follow-up question to the supplier is which.
If the report omits AAA entirely or shows a one-line "AAA passed" statement without the table: ask for the table. The integrated per-residue values are what makes AAA useful.